Few studies have examined the lung virome in health and disease. Outcomes of lung transplantation are known to be influenced by several recognized respiratory viruses, but global understanding of the virome of the transplanted lung is incomplete. To define the DNA virome within the respiratory tract following lung transplantation we carried out metagenomic analysis of allograft bronchoalveolar lavage (BAL), and compared with healthy and HIVþ subjects. Viral concentrates were purified from BAL and analyzed by shotgun DNA sequencing. All of the BAL samples contained reads mapping to anelloviruses, with high proportions in lung transplant samples. Anellovirus populations in transplant recipients were complex, with multiple concurrent variants. Quantitative polymerase chain reaction quantification revealed that anellovirus sequences were 56-fold more abundant in BAL from lung transplant recipients compared with healthy controls or HIVþ subjects (p < 0.0001). Anellovirus sequences were also more abundant in upper respiratory tract specimens from lung transplant recipients than controls (p ¼ 0.006).
Comparison to metagenomic data on bacterial populations showed that high anellovirus loads correlated with dysbiotic bacterial communities in allograft BAL (p ¼ 0.008). Thus the respiratory tracts of lung transplant recipients contain high levels and complex populations of anelloviruses, warranting studies of anellovirus lung infection and transplant outcome.
Introduction
Little is known about the virome of the human respiratory tract as a whole, though infections by individual viruses are well characterized. For the case of lung transplantation, viral infection is a major complicating factor impacting graft survival rates (1) (2) (3) (4) . Respiratory infections with known viruses can cause direct lung injury or increase risk of graft failure, as in the case of cytomegalovirus and community acquired respiratory viruses (1, 5) . Intense interest has thus focused on viruses in the respiratory tract and transplantation outcome.
Today it is possible to characterize large viral populations using high throughput metagenomic sequencing (6) (7) (8) , which has identified both well-recognized and little-studied viruses living in association with humans. Only a few studies have applied metagenomic approaches to understand viruses of the lower respiratory tract (8, 9) , and none in lung transplantation.
Anelloviruses are circular, nonenveloped, negative-sense, single-stranded DNA viruses that commonly colonize humans and show increased abundance in blood after hematopoietic and solid organ transplantation (10) (11) (12) . The anellovirus family consists of torque teno viruses (TTVs), torque teno midi viruses (TTMDVs), torque teno mini viruses (TTMVs) and small anelloviruses (SAVs), each of which has multiple subtypes (12, 13) . Their small genomes (2.3-3.8 kb) consist of three to four open reading frames (ORFs) and a highly conserved untranslated region (UTR) (12) . These viruses are ubiquitous in the human population and have not yet been causally linked with any human disease (12, 13) . Diverse types of anelloviruses have been found in various organs, tissues and cell types (12, (14) (15) (16) .
In the respiratory tract, TTV was recently identified in bronchoalveolar lavage (BAL) fluid from 28% of individuals with acute exacerbations of idiopathic pulmonary fibrosis (IPF), but not those with stable IPF, and in a quarter of individuals with acute lung injury (17) . In the upper respiratory tract, elevated levels of TTV have been found in nasal secretions from children with respiratory diseases, and correlated with disease severity (15, 16) . In HIV-infected patients, plasma concentrations of anelloviruses increased during progression to AIDS (18) and decreased following therapy (19) . TTV viremia was reported to increase following autologous hematopoietic stem cell transplantation, and then return to baseline levels following immune reconstitution (10) . Recently, TTV levels in blood were shown to increase in association with immunosuppression following lung and heart transplantation (11). The association between TTV levels and immune status has led some authors to propose that anelloviruses genome copy numbers may serve as an empirical measure of successful immune suppression (10, 11, 19) .
We report here the first study to apply viral metagenomics to understand the lung virome in lung transplantation. We first used Illumina metagenomic sequencing to characterize lung DNA viromes from lung transplant recipients, along with another immunologically impaired group, HIV-positive individuals. This showed that anellovirus sequences were prominent in BAL from transplant recipients, and revealed the presence of complex populations with multiple concurrent variants. Based on these metagenomic data, we then quantified anellovirus levels within the lungs and upper respiratory tracts of lung transplant recipients, HIVþ subjects, and healthy individuals using quantitative polymerase chain reaction (Q-PCR), demonstrating high levels of anellovirus DNA in BAL and oropharyngeal wash (OW) of lung transplant recipients. Our findings demonstrate metagenomic detection and genetic characterization of the allograft virome, which is then followed by broader quantitative analysis. We also compared metagenomic data on bacterial populations, and found that high levels of anelloviruses correlated with dysbiotic bacterial communities, revealing covariation among microbiome constituents.
Methods

Sample collection
BAL was carried out within the lung allograft on lung transplant recipients, most of whom were undergoing routine clinical surveillance bronchoscopy during the first year posttransplant (Table S1 ) as described previously (20) . OW to sample the upper respiratory tract was collected as previously described (20) . One group of control samples were obtained from healthy volunteers who underwent research bronchoscopy using the same procedure (Table S2) . Samples from three HIVþ subjects not on antiretroviral therapy (CD4 T cell counts of 301, 321, and 682; Table S3 ) and a second set from healthy volunteers (Table S2) were obtained by bronchoscopy using a previously described two-scope procedure (21) . The University of Pennsylvania IRB approved all procedures (protocols #812748 and #810851), and subjects gave written informed consent.
Virus-like particle purification
Virus-like particles (VLPs) were purified from 1 to 5 mL of BAL or OW, depending upon availability. Ten millimolars MgSO 4 and 10 mM dithiothreitol were added to the BAL or OW and filtered through a 0.22 mm filter (EMD Millipore, Billerica, MA). The filtrate was concentrated using a 100 kDa molecular weight cutoff filter (Amicon 20; Millipore), resuspended in 1 mL Buffer SM, and reconcentrated. The concentrate was treated with DNase I and RNase (Roche, Indianapolis, IN) at 378C for 15 min to eliminate nonencapsidated nucleic acids, then the enzymes were deactivated at 708C for 5 min.
Nucleic acid extraction and metagenomic sequencing
Nucleic acids were extracted from virus particle preps using the All Prep nucleic acid isolation kit (Qiagen, Valencia, CA). Six lung transplant and three HIVþ BAL samples that had large volumes of BAL and detailed patient metadata available were used for metagenomic sequencing. Whole genome amplification was performed on these samples using the GenomiPhi V2 Amplification Kit (GE Healthcare, Pittsburg, PA). Libraries for sequencing were made using Illumina's (San Diego, CA) Nextera XT DNA Sample Preparation Kit with 1 ng of input DNA, generating paired-end fragments. Metagenomic sequencing was performed on an Illumina MiSeq instrument.
Quantitative PCR
Q-PCR was carried out on non-GenomiPhi amplified DNA using primers targeting the UTR of anelloviruses from a previously-described assay (22) that we adapted to an SYBR green-based method as described in Supplemental Methods. All samples were run in duplicate or triplicate and values averaged. The detection limit was 1.4 copies per reaction.
Bioinformatics pipeline
Paired-end reads from the MiSeq instrument were quality-trimmed and processed through BMTagger to remove human sequences. Nonhuman reads were then analyzed using BLAST against the NCBI viral database. Reads were assembled into contigs by iterative deBruijn graph assembly using IDBA-UD (23) . To verify contig assembly, contig-specific PCR primers were synthesized and amplification products subjected to Sanger sequencing. Dot plots were generated using Gepard with a word size of 10 nucleotides (24) . Anellovirus ORF1 amino acid sequences were identified from our contigs and aligned along with 49 reference TTV, TTMDV, and TTMV sequences from Genbank. The phylogenetic tree was built using FastTree v2.1.3 (25) . Further details of bioinformatic analysis are provided in Supplemental Methods.
Bacterial 16S rRNA gene sequence data generated from whole BAL have been previously reported (20) . Sequences were clustered into operational taxonomic units based on 97% sequence similarity, aligned with 16S reference databases for taxonomic assignment, and pairwise UniFrac distances calculated using QIIME v1.8 (26) .
Statistical analyses
Mann-Whitney tests, paired Wilcoxon signed rank tests, t-tests and Spearman correlation tests were performed in R (27) .
Results
BAL and OW samples were collected from (1) lung transplant recipients undergoing posttransplant bronchoscopy, (2) HIVþ individuals without lung disease or respiratory symptoms and (3) healthy control subjects (20, 21) (Tables S1-S3). VLPs were purified from BAL and OW, followed by concentration and treatment with nucleases to eliminate nonencapsidated nucleic acids (Figure 1 ). DNA was then purified from each sample. To verify selective reduction in human and bacterial cells, two BAL samples were analyzed using Q-PCR to quantify bacterial 16S rRNA gene copies or human beta-tubulin gene copies. Copies of bacterial 16S DNA decreased from 3000 copies/ng in unfractionated BAL to 80 copies/ng after viral particle purification (38-fold reduction). Human beta-tubulin DNA was detected at 925 copies/ng in unfractionated BAL but became undetectable after purification (>900-fold reduction).
Metagenomic sequencing of lung transplant and HIVþ samples
We first applied metagenomic analysis to viral DNA from six lung transplant and three HIVþ BAL samples. DNA from viral preps was subjected to whole genome amplification and then shotgun sequenced using the Illumina MiSeq platform (2 Â 250 bp reads) ( Table 1 ). Up to 3.4 million reads per sample were generated, for a total of 5.42 Â 10 9 bp of sequence data. Reads were filtered and trimmed to remove low quality sequences, and human reads were identified and removed. Reads were then aligned using BLAST to the NCBI viral database (Tables 1 and S4 ).
Of reads assigned to reference viruses, the majority (>68%) mapped to anelloviruses, which included TTVs, TTMVs, TTMDVs and SAVs ( Figure 2A and Table 1 ). Based on the closest match to reference viruses, a wide variety of anelloviruses were present within the lungs of lung transplant subjects, while substantially fewer anellovirus reads were detected in lungs of HIVþ individuals ( Figure 2A ). Furthermore, diverse anelloviruses were present in single individuals, especially in the lung transplant recipients, as evidenced by reads aligning to many different TTVs, TTMVs, TTMDVs and SAVs within single samples (Table 1) .
Other eukaryotic viruses were detected within the samples, but at much lower levels. These included Epstein-Barr virus (Human Herpesvirus 4) (2 reads in one sample), Human Herpesvirus 7 (2 reads in one sample, 36 reads in another sample), and Human Papillomavirus (1 read) (Table S4 ). To determine whether use of the 0.22 mm filter step during virus purification may have resulted in depletion of some of the larger viruses, we compared filtration and centrifugation (Table S6 ). This showed that filtration resulted in reduced recovery of herpesviruses, but was more efficient at capturing small viruses such as human papillomaviruses and anelloviruses.
A small percentage of reads (0.75% of total reads for all samples combined) aligned to bacteriophage genomes, predominantly phages of Enterobacteria, Salmonella, Pseudomonas, Streptococcus and Yersinia. When bacterophages were compared with bacterial 16S sequences from these subjects that were previously analyzed (20, 28) , we found representation of several of these bacterial lineages (Streptococcus, Pseudomonas, Staphylococcus and Enterobacteria), consistent with possible phage/host pairs in our samples.
An average of 81% of the reads did not match reference viruses in the NCBI viral database, a high proportion similar to results of other viral metagenomic studies (9, 29) . We surmise that many of these may correspond to DNA phage sequences, because phage are hyperabundant globally and poorly represented in sequence databases (30) . Unidentified reads could also correspond to novel mammalian viruses or low quality reads not removed by our filtering strategy.
Genetic structure of lung anellovirus populations Anellovirus reads were assembled into contigs for more complete analysis of anelloviruses community structure, using iterative deBruijn graph assembly (23) . To validate correct contig assembly, we designed specific primer sets for three of the contigs, then PCR amplified 500-700 bp regions, sequenced using the Sanger method, and assembled using the conventional overlap method. Assembled contigs were then aligned to the NCBI nt database ( Figure 2B ). Selected regions within the anellovirus contigs were 87-93% identical to the reference sequences, though highly divergent regions were also detected. Anellovirus ORF1 and ORF2 were identified in the three anellovirus contigs. ORF1 was previously shown to encode the capsid gene and contains a hypervariable region, which may evolve rapidly to evade the host immune response (12) . The ORF2 encoded protein was reported to suppress the NF-kB pathway, thereby potentially regulating the host innate and adaptive immune response (12, 31) .
To compare anelloviruses populations within and between individuals, a phylogenetic tree was generated using ORF1 sequences from reference genomes and contigs assembled from the Illumina and Sanger sequence data. As shown in Figure 3 , multiple different anellovirus ORF1s were found within individual lung transplant patient allografts, with subjects exhibiting as many as 17 distinct contigs. In contrast, richness of anelloviruses was lower in BAL of HIVþ individuals, even though sequences were detected in all of them. Anellovirus contigs were mostly different between individuals (Figure 3 ). 
Lung Transplant Allograft Virome
Quantification of anellovirus DNA in lung and upper respiratory tract samples using Q-PCR Given diverse anellovirus populations found in some of the transplant samples, we sought to quantify absolute anellovirus DNA levels in a larger group of subjects using Q-PCR. We used the universal PCR primers targeting the anellovirus highly conserved UTR (22) to generate a Q-PCR assay. These primers recognize TTVs, TTMVs, TTMDVs and SAVs. We analyzed a total of 53 BAL samples from lung transplant recipients (n ¼ 38), HIVþ subjects (n ¼ 3) and healthy controls (n ¼ 12). To assess the upper respiratory tract, we also analyzed 24 OW samples from lung transplant recipients (n ¼ 12) and healthy controls (n ¼ 12). Metagenomic sequencing reads were searched against the NCBI viral database and the number of combined reads aligning to each anellovirus calculated for lung transplant recipients (n ¼ 6) and HIVþ subjects (n ¼ 3). (B) Multiple anelloviruses present within the lungs of lung transplant recipient Tx-24. For each of the three analyzed by Sanger sequencing (x-axis), similarity was scored versus their closest matching NCBI reference sequence (y-axis). Open reading frames (ORF) were assigned using MacVector and are illustrated on the genetic maps under the dot plots. BAL, bronchoalveolar lavage; SAV, small anellovirus; TTMDV, torque teno midi virus; TTMV, torque teno mini virus; TTV, torque teno virus.
As shown in Figure 4 , anellovirus copy numbers in lung ranged widely among transplant recipients, with a median of 15 133 copies/mL (range ¼ 314-2.3 Â 10 7 copies/mL). These levels were far higher than in lungs of healthy or HIVþ subjects (medians of 271 and 191 copies/mL, respectively; p < 0.0001 and p ¼ 0.0004, respectively, for comparison to lung transplant samples; Mann-Whitney test).
Quantities of anelloviruses in the upper respiratory tract were also measured in OW collected from lung transplant recipients and healthy subjects. As was seen in lung, anellovirus genome copies were significantly more abundant in the upper respiratory tract of transplant recipients compared with healthy controls ( Figure 5 ) (median ¼ 16 700 in transplant recipients, range ¼ 634-632 759 copies/mL compared to median ¼ 1033 in healthy individuals; p ¼ 0.0044). When quantities of anellovirus were compared between lung and upper respiratory tract within the same treatment group, healthy subjects had significantly lower titers in their BAL compared to OW (p ¼ 0.0068, MannWhitney test). However, in lung transplant recipients, anellovirus genome copies were higher in both sample types and not significantly different in lung compared to the upper respiratory tract (p ¼ 0.23, Figure 6 ).
Comparison of anellovirus DNA levels to transplant subject metadata We then asked whether anellovirus levels in the transplant recipients' lungs were correlated with clinical variables that might explain the high variability. We queried patient age, gender, time since transplant, number of immunosuppressive drugs, tacrolimus levels, prednisone dosing, target Figure 3 : Diversity of anellovirus ORF1 sequences in samples from each individual studied. ORF1 amino acid sequences from anellovirus contigs and Genbank reference sequences were aligned and trimmed to generate the phylogenetic tree shown. The names of the reference sequences include the TTV strain name followed by the Genbank identification (gi) number. Clades are designated as groups, in the outer ring, as described in references (12) and (22) . The BAL sample of origin of each ORF1 sequence is designated by the color code (key at right). The Shimodaira-Hasegawa (SH) score was calculated using FastTree to estimate the reliability of each split compared to alternate topologies (25) . Local SH support values over 0.9 are labeled as circles on the nodes of the tree. The scale bar represents the number of amino acid substitutions per position. ORF, open reading frame; SAV, small anellovirus; TTMDV, torque teno midi virus; TTMV, torque teno mini virus; TTV, torque teno virus.
immunosuppression range, surgical type (single vs. bilateral lung transplant), use of azithromycin, cytomegalovirus status (donor and recipient), BAL bacterial culture results and bacterial load in BAL based on 16S rRNA gene Q-PCR, acute rejection grade and pretransplant diagnosis (suppurative vs. nonsuppurative lung disease). No significant associations were detected (Table S5 ). Though power was limited by the relatively small sample sizes, these data suggest that anellovirus replication in the lung allograft is linked to factors other than these clinical variables.
Comparison of lung anellovirus DNA levels to the bacterial microbiome Finally, we asked whether there was a relationship between anellovirus DNA levels and composition of the bacterial microbiome in allografts. Previously, DNA was purified from whole BAL, PCR amplified using primers that recognize conserved regions of the bacterial 16S rRNA gene, and products analyzed by deep sequencing (20) . That analysis showed that lung transplant bacterial communities differed in composition from healthy subjects, and transplant recipients were commonly colonized by oral bacteria, known pathogenic bacteria and sometimes by unexpected bacterial lineages. Absolute levels of bacteria were also higher than in healthy controls (40-to 100-fold). Here we compared the anellovirus titers with bacterial community composition among transplant recipients, and found a significant correlation (Figure 7 ; weighted UniFrac, p ¼ 0.032). However, no specific bacterial lineages were significantly linked to anellovirus levels among transplant subjects. We then asked if the relationship between anellovirus and 16S bacterial composition might be linked to the degree to which the bacterial communities diverged from healthy controls. This analysis revealed a significant correlation between transplant BAL anellovirus levels and a metric measuring the divergence between the corresponding bacterial community and those of healthy subjects ( Figure S1 ; p ¼ 0.008). Thus, high anellovirus levels in transplant recipients are also associated with aberrant bacterial microbiota.
Discussion
Here we used metagenomic sequencing to analyze DNA viruses present in the respiratory tract of lung transplant recipients and HIV-infected individuals. The metagenomic data then enabled targeted analysis of anellovirus levels in a larger cohort of lung transplant and control subjects. This is the first study to apply viral metagenomics to the lung transplant allograft. Multiple viruses infecting animal cells were detected by sequencing, including a remarkable abundance and complexity of anelloviruses, as well as much lower levels of papilloma viruses and herpes viruses. Bacteriophage were also detectable, as were unidentified sequences likely corresponding at least in part to phages. Our most notable finding was that the anelloviruses, including TTVs, TTMDVs, TTMVs and SAVs, were greatly increased in abundance in the lungs and the upper respiratory tract of lung transplant recipients compared with healthy and HIVþ subjects. As this work was being completed, De Vlaminck et al reported that anellovirus sequences were increased in abundance in blood in organ transplant recipients (11) . Our data reported here show that after lung transplantation, anellovirus sequences are abundant in the lung allograft itself.
The shotgun metagenomic sequence data enabled assembly of near-complete genome sequences for some of the most abundant anelloviruses, allowing the genetic nature of anelloviruses present to be analyzed in detail. A notable feature of transplant recipients was the great diversity of anelloviruses represented within single individuals. Quantifying the exact number of different forms is challenging and dependent on the metric chosen. Taking each independent contig into account, there were up to 247 contigs identified as anelloviruses within one sample (Tx-24). However, this may be an overestimate because some contigs are only partial genomes (sizes ranged from 250 to 3600 bp), though this is hard to assess definitively because replicationcompetent subviral molecules have been reported (32) .
Analysis based on viral ORF1 regions showed that up to 17 different anelloviruses were present within a single transplant recipient (Tx-24), indicating remarkable diversity. Some of the anelloviruses identified in these subjects were distant in sequence from database genomes. Such high divergence was confirmed in the three genomes reconstructed by Sanger sequencing, and so is not a result of error in Illumina sequence determination or assembly. The origin of this extreme diversity is unclear, but may be due in part to the known high mutation rates of single-stranded DNA viruses (33) combined with high virus levels likely reflecting high rates of virus replication in lung.
We found large numbers of bacteriophage sequences in our shotgun metagenomic data, likely due to the abundant bacterial populations in lung transplant subjects (20) , but relatively few mammalian DNA viruses besides anelloviruses. This is likely in large part related to the near-universal use of herpesviruses prophylaxis in transplant subjects, and relatively modest level of immune dysfunction based on CD4þ T cell counts in our HIVþ subjects. In addition, samples for metagenomic analysis were subject to multiple displacement amplification, which favors small circular genomes such as anelloviruses. An additional technical factor may be that the filtration step used could have depleted large viruses or viral particles bound to other macromolecules, although reconstruction experiments suggest that the losses were modest. In addition, a large proportion of sequences did not match any database (20)) and analyzed using weighted UniFrac, which generated a set of pairwise distances among samples. The distances were then analyzed using Principal Coordinate Analysis (PCoA), and the samples plotted along the first two principal coordinates. For each sample, the anellovirus titer is summarized by the size of the open circle. Among these transplant recipient BALs there is a significant relationship between anellovirus DNA level and 16S bacterial community composition, which is reflected in the observation that samples with low anellovirus titers tend to appear on the lower left side of the PCoA plot (p ¼ 0.032; ADONIS test). BAL, bronchoalveolar lavage.
genomes, which is concordant with findings in other metagenomic virome studies (6, 9, 29) . While many of these are likely novel bacterophages, it is possible that novel mammalian viruses may exist within those sequences as well. One limitation of our sample set is the relatively short elapsed time since transplant (median of 5 months), and it will be useful to investigate whether additional viral lineages emerge over longer times.
Anellovirus genome copy numbers in lung from Q-PCR data were remarkably different among transplant subjects, varying across nearly 5 orders of magnitude. However, comparison to standard patient metadata did not show significant correlations with any of the clinical parameters queried. A recent study of anellovirus in serum following organ transplantation reported that anellovirus genome levels correlated with the extent of immunosuppression, suggesting that anellovirus DNA in blood might serve as an assay for the overall level of immunosuppression (11) . In contrast, our subjects were receiving relatively homogenous immunosuppression regimens (Table S1 ), and we found no association with any measure of immunosuppression, nor with time since transplant (Table S5) . Thus, the absence of correlations seen here between lung anellovirus levels and clinical variables suggests that anellovirus replication in lung allografts may be regulated by factors that have yet to be identified.
We compared anellovirus DNA quantification to previously determined data on the structure of bacterial communities, and identified a novel form of covariation. Among transplant recipients, BAL samples with high anellovirus levels differed from those with lower levels based on the bacterial 16S data. Furthermore, samples with highest levels of anellovirus were more divergent from the bacterial communities of healthy controls, indicating bacterial dysbiosis. This suggests that the anellovirus and bacterial communities may both be responding to some common property of the host, such as loss of immune control. If so, the immune impairment would not be reflected by standard clinical measures, which did not correlate with features of anelloviral DNA levels. The correlation between anellovirus titers and bacterial dysbiosis was imperfect, however, indicating that there are likely both shared and unique factors influencing viral and bacterial microbiota, respectively. In summary, our results employing shotgun metagenomic sequencing revealed robust anellovirus populations in lungs of lung transplant recipients, which was then confirmed and quantified by targeted Q-PCR. Long-term lung transplant outcomes have been linked to prior infection with several other viruses (1,2,4). While our subjects were sampled at relatively early time points (median 5 months posttransplant), early posttransplant colonization with other microbial agents has been associated with BOS at later time points (34, 35) . Thus, the finding of unexpected high levels of anellovirus replication within lung allografts and marked inter-subject variability suggest that longitudinal studies are warranted to determine whether levels of anelloviruses in the lung allograft are associated with, and may play a role in, transplant outcomes.
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